Novo Nordisk reimburses its staff who’ve been prescribed the drugs it develops — including its expensive weight loss drug Wegovy, Bloomberg reported Nov. 15. The drugmaker employs about 21,000 people in Denmark.
Read the full post on Becker's Hospital Review - Healthcare News
